MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health

Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

Recent Posts

See All

Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership

Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...

MVT and Soundjet Announce Collaboration Aiming to Bring New Treatment Options to Patients with Vascular Thrombosis

Microvascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...

Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100

Tucson, AZ – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the...

Comments

Commenting has been turned off.